The symptoms of this inflammatory disease can seem disconnected, which is why it’s important to know what to look for.

Discover a study showing low and stable cancer risk in patients with PsO, PsA, and axSpA treated long-term with ixekizumab.

Market OverviewThe global Cancer Immunotherapy Market is valued at USD 121.4 Billion in 2024 and is projected to reach a ...